Enanta Pharmaceuticals (ENTA) PT Lowered to $114 at JMP Securities
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $13.16 --0%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
JMP Securities analyst Roy Buchanan lowered the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $114.00 (from $116.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
- Integer Holding (ITGR) PT Raised to $17 at Truist Securities
- Spruce Biosciences, Inc. (SPRB) PT Lowered to $104 at Guggenheim
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
